The Hill covers research pairing GLP-1 drugs with other treatment for psoriasis, a topic doctors have been watching closely.
Recap by typeshit. Full story at The Hill.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
Lilly Medical points to newly published results from a double-blind, placebo-controlled phase 3 study of its triple-hormone shot in people with diabetes.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
Medscape reports strong weight loss results for teens on GLP-1 medications, while noting there's still little data on long-term effects or growth.
US Anti-Doping's Dr Matt Fedoruk gives athletes a short rundown on peptides, covering what is prohibited in sport and what is allowed.
Loading…